Who Supplies Fosfomycin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Fosfomycin exports, with 73+ registered manufacturers shipping to buyers across 46+ countries — yet a handful of companies dominate the shipments. CIPLA LIMITED holds the largest share at 50.9% (export value: $6.6M). Close behind, SWISS PARENTERALS LIMITED (8.9%, $1.2M). AMNEAL PHARMACEUTICALS PRIVATE LIMITED (1.7%, $215.4K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Fosfomycin? Top Manufacturers & Their Buyers
Flow of Fosfomycin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Fosfomycin Supplier Network — Key Market Intelligence
The Fosfomycin export market from India is led by CIPLA LIMITED, which alone commands a 50.9% share, shipping $6.6M worth of product across 120 shipments. The second-largest exporter, SWISS PARENTERALS LIMITED, contributes $1.2M (8.9%) to the overall market. Combined, the top two suppliers alone account for 59.9% of all Fosfomycin exports, indicating a relatively concentrated supply base.
Across all 73 tracked manufacturers, the total Fosfomycin export value stands at $12.9M from 492 shipments. The market average shipment value is $26.2K. The single largest buyer relationship in terms of trade value is CIPLA USA INC UPS SUPPLY CHAIN SOL, receiving $5.1M worth of product.
The combined buyer network spans 8 named purchasing companies, including CIPLA USA INC UPS SUPPLY CHAIN SOL, KIND ATTN; MR. JAUME, AMNEAL PHARMACEUTICALS, LLC (KY), MCHZH KONARK PHARM, AVIV FARMACEUTICA S.ACALZADA and 3 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1CIPLA LIMITED
CIPLA LIMITED is the first-largest Fosfomycin exporter from India, with a market share of 50.9% and a total export value of $6.6M across 120 shipments. Their average shipment value of $54.7K is above the market average of $26.2K, suggesting premium or bulk contract pricing.
CIPLA LIMITED serves 3 named buyers in our database. CIPLA USA INC UPS SUPPLY CHAIN SOL is the dominant customer, accounting for 77.5% of this supplier's tracked business. Top customers include:
• CIPLA USA INC UPS SUPPLY CHAIN SOL — $5.1M across 93 shipments (77.5% of this supplier's total exports)
• CIPLA USA INC UPS SUPPLY CHAIN SOL — $1.5M across 27 shipments (22.4% of this supplier's total exports)
• KIND ATTN; MR. JAUME — $3.6K across 0 shipments (0.1% of this supplier's total exports)
Key Insight: CIPLA LIMITED's per-shipment value of $54.7K is 109% above the market average of $26.2K, consistent with large-order contracts or value-added formulations.
2SWISS PARENTERALS LIMITED
SWISS PARENTERALS LIMITED is the second-largest Fosfomycin exporter from India, with a market share of 8.9% and a total export value of $1.2M across 27 shipments. Their average shipment value of $42.7K is above the market average of $26.2K, suggesting premium or bulk contract pricing.
SWISS PARENTERALS LIMITED serves 4 named buyers in our database. TO THE ORDER OF is the dominant customer, accounting for 84.7% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF — $976.1K across 23 shipments (84.7% of this supplier's total exports)
• TO THE ORDER — $140.6K across 3 shipments (12.2% of this supplier's total exports)
• TO THE ORDER OF — $19.5K across 0 shipments (1.7% of this supplier's total exports)
• TO THE ORDER OF — $16.5K across 0 shipments (1.4% of this supplier's total exports)
Key Insight: SWISS PARENTERALS LIMITED's per-shipment value of $42.7K is 63% above the market average of $26.2K, consistent with large-order contracts or value-added formulations.
3AMNEAL PHARMACEUTICALS PRIVATE LIMITED
AMNEAL PHARMACEUTICALS PRIVATE LIMITED is the third-largest Fosfomycin exporter from India, with a market share of 1.7% and a total export value of $215.4K across 3 shipments. Their average shipment value of $71.8K is above the market average of $26.2K, suggesting premium or bulk contract pricing.
AMNEAL PHARMACEUTICALS PRIVATE LIMITED serves 1 named buyer in our database. AMNEAL PHARMACEUTICALS, LLC (KY) is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• AMNEAL PHARMACEUTICALS, LLC (KY) — $215.4K across 3 shipments (100.0% of this supplier's total exports)
Key Insight: AMNEAL PHARMACEUTICALS PRIVATE LIMITED's per-shipment value of $71.8K is 174% above the market average of $26.2K, consistent with large-order contracts or value-added formulations.
4AVANTIKA MEDEX PRIVATE LIMITED
AVANTIKA MEDEX PRIVATE LIMITED is the fourth-largest Fosfomycin exporter from India, with a market share of 1.3% and a total export value of $172.6K across 6 shipments. Their average shipment value of $28.8K is above the market average of $26.2K, suggesting premium or bulk contract pricing.
AVANTIKA MEDEX PRIVATE LIMITED serves 1 named buyer in our database. MCHZH KONARK PHARM is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• MCHZH KONARK PHARM — $172.6K across 6 shipments (100.0% of this supplier's total exports)
Key Insight: AVANTIKA MEDEX PRIVATE LIMITED's per-shipment value of $28.8K is 10% above the market average of $26.2K, consistent with large-order contracts or value-added formulations.
5SRS PHARMACEUTICALS PRIVATE LIMITED
SRS PHARMACEUTICALS PRIVATE LIMITED is the fifth-largest Fosfomycin exporter from India, with a market share of 1.0% and a total export value of $131.3K across 9 shipments. Their average shipment value of $14.6K is below the market average of $26.2K, reflecting a high-volume, competitive pricing strategy.
SRS PHARMACEUTICALS PRIVATE LIMITED serves 3 named buyers in our database. AVIV FARMACEUTICA S.ACALZADA is the dominant customer, accounting for 83.0% of this supplier's tracked business. Top customers include:
• AVIV FARMACEUTICA S.ACALZADA — $109.1K across 7 shipments (83.0% of this supplier's total exports)
• AV.12 DE OCTUBRE N26 — $21.9K across 2 shipments (16.7% of this supplier's total exports)
• NORTH LIFE PHARMA EC — $340 across 0 shipments (0.3% of this supplier's total exports)
Key Insight: SRS PHARMACEUTICALS PRIVATE LIMITED operates with high shipment frequency (9 shipments) at a per-shipment value of $14.6K, indicating a broad distribution network with many smaller, regular orders.
6INDASI LIFESCIENCE PRIVATE LIMITED
INDASI LIFESCIENCE PRIVATE LIMITED is the fifth-largest Fosfomycin exporter from India, with a market share of 1.0% and a total export value of $122.7K across 6 shipments. Their average shipment value of $20.5K is below the market average of $26.2K, reflecting a high-volume, competitive pricing strategy.
INDASI LIFESCIENCE PRIVATE LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• AVIV FARMACEUTICA SA — $40.3K across 2 shipments (32.8% of this supplier's total exports)
• AVIV FARMACEUTICA S.ACALZADA — $33.0K across 2 shipments (26.9% of this supplier's total exports)
• AVIV FARMACEUTICA S.ACALZADA — $25.0K across 1 shipments (20.4% of this supplier's total exports)
• AVIV FARMACEUTICA S.ACALZADA — $24.5K across 1 shipments (19.9% of this supplier's total exports)
Key Insight: INDASI LIFESCIENCE PRIVATE LIMITED operates with high shipment frequency (6 shipments) at a per-shipment value of $20.5K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Fosfomycin Flows
Once Fosfomycin leaves the manufacturing plants of companies like CIPLA LIMITED and SWISS PARENTERALS LIMITED, it travels to 5 destination markets with a combined import value of $12.9M. United States absorbs the largest share at 76.9% ($9.9M), followed by Germany (9.3%) and Guatemala (3.9%).
In United States — the top destination — named importers include CIPLA USA INC UPS SUPPLY CHAIN SOLU, CIPLA USA INC UPS SUPPLY CHAIN SOL, AMNEAL PHARMACEUTICALS, LLC (KY).
This geographic spread reflects Fosfomycin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Fosfomycin Go? Top Importing Countries & Their Buyers
Trade flow of Fosfomycin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Fosfomycin imports from India, with a total trade value of $9.9M across 123 shipments — representing a 76.9% share of all Fosfomycin exports. The average shipment value of $80.6K is above the global average of $26.2K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Fosfomycin importers in United States: CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest buyer, accounting for 81.2% ($8.1M) of this market's total imports.
• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $8.1M (81.2% of United States's total)
• CIPLA USA INC UPS SUPPLY CHAIN SOL — $1.5M (15.6% of United States's total)
• AMNEAL PHARMACEUTICALS, LLC (KY) — $215.4K (2.2% of United States's total)
Key Insight: United States's per-shipment average of $80.6K (208% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Fosfomycin imports from India.
2Germany
Germany ranks as the second-largest destination for Fosfomycin imports from India, with a total trade value of $1.2M across 0 shipments — representing a 9.3% share of all Fosfomycin exports. The average shipment value of $1.2M is above the global average of $26.2K, indicating high-value procurement contracts or branded formulations.
Key Insight: Germany's per-shipment average of $1.2M (4499% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Germany is a key market for Fosfomycin imports from India.
3Guatemala
Guatemala ranks as the third-largest destination for Fosfomycin imports from India, with a total trade value of $505.6K across 9 shipments — representing a 3.9% share of all Fosfomycin exports. The average shipment value of $56.2K is above the global average of $26.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Fosfomycin importers in Guatemala: AVIV FARMACEUTICA S.A is the largest buyer, accounting for 48.1% ($243.1K) of this market's total imports.
• AVIV FARMACEUTICA S.A — $243.1K (48.1% of Guatemala's total)
• AVIV FARMACEUTICA S.ACALZADA — $25.0K (4.9% of Guatemala's total)
Key Insight: Guatemala's per-shipment average of $56.2K (115% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Guatemala is a key market for Fosfomycin imports from India.
4Tunisia
Tunisia ranks as the fourth-largest destination for Fosfomycin imports from India, with a total trade value of $497.4K across 0 shipments — representing a 3.9% share of all Fosfomycin exports. The average shipment value of $497.4K is above the global average of $26.2K, indicating high-value procurement contracts or branded formulations.
Key Insight: Tunisia's per-shipment average of $497.4K (1799% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Tunisia is a key market for Fosfomycin imports from India.
5Uzbekistan
Uzbekistan ranks as the fifth-largest destination for Fosfomycin imports from India, with a total trade value of $172.6K across 6 shipments — representing a 1.3% share of all Fosfomycin exports. The average shipment value of $28.8K is above the global average of $26.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Fosfomycin importers in Uzbekistan: MCHZH KONARK PHARM is the largest buyer, accounting for 100.0% ($172.6K) of this market's total imports.
• MCHZH KONARK PHARM — $172.6K (100.0% of Uzbekistan's total)
Key Insight: Uzbekistan's per-shipment average of $28.8K (10% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Uzbekistan is a key market for Fosfomycin imports from India.
People Also Ask — Fosfomycin Supplier & Trade Network
Who are the top suppliers of Fosfomycin from India?+
Which companies buy Fosfomycin from Indian manufacturers?+
Where does Fosfomycin exported from India go?+
What is the market share of the top Fosfomycin supplier from India?+
What is the average shipment value for Fosfomycin exports from India?+
Is Fosfomycin manufactured in India and exported globally?+
Which country imports the most Fosfomycin from India?+
Who are the buyers of Fosfomycin in Germany?+
How concentrated is the Fosfomycin supplier market in India?+
How do I find verified buyers for Fosfomycin in specific countries?+
Fosfomycin Trade Network — Key Takeaways
- 1CIPLA LIMITED is India's dominant Fosfomycin exporter with a 50.9% market share and $6.6M in total exports — making it the single most important sourcing entity in this market.
- 2The top 73 suppliers collectively account for 64.9% of all tracked Fosfomycin exports, with a combined trade value of $12.9M.
- 3United States is the largest destination market, absorbing 76.9% of India's Fosfomycin exports ($9.9M). Germany (9.3%) and Guatemala (3.9%) follow.
- 4With 492 total shipments averaging $26.2K each, the Fosfomycin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include CIPLA USA INC UPS SUPPLY CHAIN SOL, CIPLA USA INC UPS SUPPLY CHAIN SOL, AMNEAL PHARMACEUTICALS, LLC (KY), MCHZH KONARK PHARM — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 3 customers
6 suppliers → 46 countries
Network value: $12.9M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fosfomycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Fosfomycin.
- 2.Flow Mapping: 73 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 492 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 46 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
492 Verified Shipments
73 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists